Medtronic (NYSE: MDT) has completed its acquisition of privately held CathWorks in a transaction valued at up to 585 million, including potential earn‑outs. The deal follows a 2022…
New rapid test for fentanyl exposure Labcorp (NYSE: LH) has launched the Labcorp Fentanyl Urine Visual Test, billed as the first FDA‑cleared rapid fentanyl test of its…
March 18, 2026
Fulgent Genetics Closes Dual Pathology Deal
Fulgent Genetics ( NASDAQ: FLGT) has finalized its acquisition of two specialty pathology laboratories — Bako Diagnostics and StrataDx, for approximately $56.9 million in cash,…